Alnylam Pharmaceuticals
ALNY
#453
Rank
A$77.59 B
Marketcap
A$587.35
Share price
-5.11%
Change (1 day)
47.53%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: A$736.88 AUD on 2025-10-20

Lowest end of day price: A$5.93 AUD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Annual Stock Price Performance

Year Performance
2025 76.62%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$102.61-3.41%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1,105-1.34%๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.00-1.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.06-1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.24 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$197.80-0.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$72.88-0.56%๐Ÿ‡ซ๐Ÿ‡ท France
A$44.81-1.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel